e-learning
resources
Virtual 2021
07.09.2021
COVID - 19, smoking and e-cigarettes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients – nationwide data from Denmark
A. Løkke (Odense, Denmark), O. Hilberg (Odense, Denmark), J. Lykkegaard (Odense, Denmark), R. Ibsen (Aarhus, Denmark), G. Stratelis (Södertälje, Sweden), S. de Fine Licht (Södertälje, Sweden), P. Lange (Copenhagen, Denmark)
Source:
Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes
Session:
COVID - 19, smoking and e-cigarettes
Session type:
E-poster
Number:
3213
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Løkke (Odense, Denmark), O. Hilberg (Odense, Denmark), J. Lykkegaard (Odense, Denmark), R. Ibsen (Aarhus, Denmark), G. Stratelis (Södertälje, Sweden), S. de Fine Licht (Södertälje, Sweden), P. Lange (Copenhagen, Denmark). Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients – nationwide data from Denmark. 3213
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Late Breaking Abstract - Diagnosis of chronic obstructive pulmonary disease (COPD) exacerbations using a smartphone-based, cough-centred algorithm
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
Does Nutritional Risk Screening 2002 correlate with dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Late Breaking Abstract - Frequency Pulmonary embolism (PE) in patients with an acute Exacerbation of chronic obstructive Pulmonary disease (COPD). PEP prospective trial.
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Source: Eur Respir J 2013; 41: 548-555
Year: 2013
Clinical and epidemiological characteristics of chronic obstructive pulmonary disease (COPD) patients in Spain (VICE Study)
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003
Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort: Disease management in primary care: Descriptive data
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017
The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol
Source: Eur Respir J 2013; 41: 1017-1022
Year: 2013
Impact of chronic obstructive pulmonary disease (COPD) and patients' absence from work in Greece - the GOLDEN II study
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept